Combining these biological factors, therefore, may provide a relatively comprehensive evaluation of the hallmarks of that particular tumor, encompassing molecular pathogenesis and mutation status (HPV, p16), immune response to the tumor (TILs), and the state of cell-cycle control and apoptotic mechanisms (survivin, p16). This evidence concerns the gene BIRC5 and neoplasm.